Xometry, Inc. $XMTR Shares Acquired by Algert Global LLC

Key Points

• Algert Global LLC significantly increased its stake in Xometry, Inc. by 208.5% in the first quarter, acquiring an additional 55,330 shares to own approximately 0.16% of the company.
• Xometry reported $162.55 million in revenue for the last quarter, a 22.6% increase year-over-year, and exceeded the earnings per share consensus estimate by $0.04.
• Analysts have a Moderate Buy rating on Xometry with an average price target of $40.44, reflecting positive expectations for the company's stock performance.

Algert Global LLC increased its position in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 208.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,865 shares of the company's stock after buying an additional 55,330 shares during the period. Algert Global LLC owned about 0.16% of Xometry worth $2,040,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Roubaix Capital LLC acquired a new position in shares of Xometry in the first quarter valued at approximately $2,045,000. Raymond James Financial Inc. raised its position in shares of Xometry by 1.5% in the first quarter. Raymond James Financial Inc. now owns 292,327 shares of the company's stock valued at $7,285,000 after buying an additional 4,366 shares during the last quarter. Nuveen LLC acquired a new position in shares of Xometry in the first quarter valued at approximately $14,639,000. Zevenbergen Capital Investments LLC raised its position in shares of Xometry by 5.1% in the first quarter. Zevenbergen Capital Investments LLC now owns 10,250 shares of the company's stock valued at $255,000 after buying an additional 500 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Xometry by 54.0% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 187,064 shares of the company's stock valued at $4,662,000 after buying an additional 65,625 shares during the last quarter. Institutional investors and hedge funds own 97.31% of the company's stock.

Insider Transactions at Xometry

In other Xometry news, CEO Randolph Altschuler sold 9,332 shares of the business's stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $32.39, for a total transaction of $302,263.48. Following the completion of the sale, the chief executive officer directly owned 319,602 shares in the company, valued at $10,351,908.78. The trade was a 2.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 9.66% of the stock is currently owned by corporate insiders.

Xometry Price Performance

XMTR opened at $46.57 on Friday. The company has a quick ratio of 3.85, a current ratio of 3.91 and a debt-to-equity ratio of 1.20. Xometry, Inc. has a 52-week low of $16.11 and a 52-week high of $48.60. The company has a 50 day moving average of $36.27 and a two-hundred day moving average of $31.39. The company has a market cap of $2.37 billion, a P/E ratio of -37.86 and a beta of 0.83.

Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.04. Xometry had a negative net margin of 10.20% and a negative return on equity of 6.79%. The company had revenue of $162.55 million during the quarter, compared to the consensus estimate of $156.53 million. During the same period in the previous year, the firm earned ($0.01) earnings per share. Xometry's revenue for the quarter was up 22.6% on a year-over-year basis. Xometry has set its Q3 2025 guidance at EPS. On average, analysts expect that Xometry, Inc. will post -0.66 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on XMTR shares. Royal Bank Of Canada boosted their price objective on shares of Xometry from $32.00 to $36.00 and gave the company a "sector perform" rating in a research report on Wednesday, May 7th. The Goldman Sachs Group boosted their target price on shares of Xometry from $33.00 to $42.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. JMP Securities boosted their target price on shares of Xometry from $45.00 to $50.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. JPMorgan Chase & Co. boosted their target price on shares of Xometry from $36.00 to $38.00 and gave the company an "overweight" rating in a report on Tuesday, June 3rd. Finally, Cantor Fitzgerald upgraded shares of Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 target price for the company in a report on Tuesday, August 5th. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $40.44.

Xometry Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.